Published in Am J Pathol on February 01, 1998
Visualization of microtubule growth in living platelets reveals a dynamic marginal band with multiple microtubules. Blood (2008) 2.20
FlnA-null megakaryocytes prematurely release large and fragile platelets that circulate poorly. Blood (2011) 1.72
Histone deacetylase 6-mediated deacetylation of α-tubulin coordinates cytoskeletal and signaling events during platelet activation. Am J Physiol Cell Physiol (2013) 1.53
Actin dynamics in platelets. Int Rev Cytol (2002) 0.99
Troubleshooting in platelet storage temperature and new perspectives through proteomics. Blood Transfus (2010) 0.96
The hibernating 13-lined ground squirrel as a model organism for potential cold storage of platelets. Am J Physiol Regul Integr Comp Physiol (2012) 0.92
Motor-driven marginal band coiling promotes cell shape change during platelet activation. J Cell Biol (2014) 0.92
Hemostatic function of apheresis platelets stored at 4°C and 22°C. Shock (2014) 0.82
The beta 1 tubulin R307H single nucleotide polymorphism is associated with treatment failures in immune thrombocytopenia (ITP). Br J Haematol (2012) 0.80
Temperature effects on the activity, shape, and storage of platelets from 13-lined ground squirrels. J Comp Physiol B (2017) 0.75
Balance of microtubule stiffness and cortical tension determines the size of blood cells with marginal band across species. Proc Natl Acad Sci U S A (2017) 0.75
Taxol stabilizes microtubules in mouse fibroblast cells. Proc Natl Acad Sci U S A (1980) 8.94
Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia. J Am Chem Soc (1971) 8.56
Fine structural alterations induced in platelets by adenosine diphosphate. Blood (1968) 4.95
Mechanisms of actin rearrangements mediating platelet activation. J Cell Biol (1992) 3.28
Interaction of membrane systems in blood platelets. Am J Pathol (1972) 2.32
An ultrastructural basis for the shape changes induced in platelets by chilling. Blood (1967) 2.20
Further studies on microtubules. A marginal bundle in human and rat thrombocytes. J Ultrastruct Res (1965) 2.11
The cytoskeleton of the resting human blood platelet: structure of the membrane skeleton and its attachment to actin filaments. J Cell Biol (1991) 2.11
Reorganization of actin in platelets stimulated by thrombin as measured by the DNase I inhibition assay. Proc Natl Acad Sci U S A (1979) 2.02
Biochemical studies of two patients with the gray platelet syndrome. Selective deficiency of platelet alpha granules. J Clin Invest (1980) 2.01
Taxol induces postmitotic myoblasts to assemble interdigitating microtubule-myosin arrays that exclude actin filaments. J Cell Biol (1981) 1.94
Inhibition of actin polymerization in blood platelets by cytochalasins. Nature (1981) 1.92
Microtubules in hamster platelets. J Cell Biol (1965) 1.89
Influence of cytochalasin B on the shape change induced in platelets by cold. Blood (1973) 1.72
Incomplete microtubules observed in mammalian blood platelets during microtubule polymerization. J Cell Biol (1967) 1.66
Effects of colchicine and Vinca alkaloids on human platelets. I. Influence on platelet microtubules and contractile function. Am J Pathol (1968) 1.53
[Microtubules and fibrils in spread-out platelets]. Nouv Rev Fr Hematol (1966) 1.33
Actin filament content and organization in unstimulated platelets. J Cell Biol (1984) 1.28
Mechanism of shape change in chilled human platelets. Blood (1995) 1.05
Surface-activated bovine platelets do not spread, they unfold. Am J Pathol (1990) 0.99
Influence of taxol on the response of platelets to chilling. Am J Pathol (1982) 0.96
Dynamics of membrane-cytoskeleton interactions in activated blood platelets. Biochemistry (1982) 0.94
Microtubule coils in spread blood platelets. Blood (1984) 0.93
Comparison of bovine and human platelet deformability, using micropipette elastimetry. Am J Vet Res (1989) 0.86
Platelet structural physiology: the ultrastructure of adhesion, secretion, and aggregation in arterial thrombosis. Cardiovasc Clin (1987) 0.85
Microtubule reassembly in surface-activated platelets. Blood (1985) 0.83
An overview of platelet structural physiology. Scanning Microsc (1987) 0.83
Temperature cycling preserves platelet shape and enhances in vitro test scores during storage at 4 degrees. J Lab Clin Med (1978) 0.82
Actin cytoskeleton of resting bovine platelets. Exp Cell Res (1990) 0.81
Heterogeneity in filamentous actin content among individual human blood platelets. Blood (1992) 0.80
Influence of microtubule stabilization on platelet physiology. Trans Assoc Am Physicians (1982) 0.78
Ultrastructural physiology of platelets with randomly dispersed rather than circumferential band microtubules. Am J Pathol (1983) 0.78
Biochemical studies of two patients with the gray platelet syndrome. Selective deficiency of platelet alpha granules. J Clin Invest (1980) 2.01
Albinism and Hermansky-Pudlak syndrome in Puerto Rico. Bol Asoc Med P R (1990) 1.79
Effects of the lonophore A23187 on blood platelets I. Influence on aggregation and secretion. Am J Pathol (1974) 1.59
Localization of platelet prostaglandin production in the platelet dense tubular system. Am J Pathol (1976) 1.40
Investigation of the release reaction in platelets exposed to phorbol myristate acetate. Am J Pathol (1974) 1.39
Effects of the lonophore A23187 on the blood platelets II. Influence on ultrastructure. Am J Pathol (1974) 1.27
Alteration in the balance of prostaglandin and thromboxane synthesis in diabetic rats. J Lab Clin Med (1980) 1.23
Influence of epinephrine on the aggregation response of aspirin-treated platelets. Prostaglandins Med (1980) 1.18
Platelet interaction with bacteria. IV. Stimulation of the release reaction. Am J Pathol (1975) 1.12
Measurement of ionized calcium in blood platelets with a new generation calcium indicator. Biochem Biophys Res Commun (1985) 1.07
An actin-binding protein in human platelets. Interactions with alpha-actinin on gelatin of actin and the influence of cytochalasin B. Am J Pathol (1978) 1.07
Use of plasma glow for surface-engineering biomolecules to enhance bloodcompatibility of Dacron and PTFE vascular prosthesis. Biomaterials (2000) 1.06
Labile aggregation stimulating substance (LASS): the factor from storage pool deficient platelets correcting defective aggregation and release of aspirin treated normal platelets. Br J Haematol (1975) 1.05
Platelet dysfunction induced by parenteral carbenicillin and ticarcillin. Studies of the dose-response relationship and mechanism of action in dogs. Am J Pathol (1978) 1.03
Influence of the ionophore A23187 on the plastic behavior of normal erythrocytes. Am J Pathol (1977) 1.03
Surface-activated bovine platelets do not spread, they unfold. Am J Pathol (1990) 0.99
Epinephrine reverses the inhibitory influence of aspirin on platelet-vessel wall interactions. Thromb Res (1986) 0.99
Effects of a microtubule stabilizing agent on the response of platelets to vincristine. Blood (1982) 0.97
Recycling of platelet phosphorylation and cytoskeletal assembly. J Cell Biol (1984) 0.96
Influence of a microtubule stabilizing agent on platelet structural physiology. Am J Pathol (1983) 0.93
Use of the electron microscope for diagnosis of platelet disorders. Semin Thromb Hemost (1998) 0.92
Effect of docosahexaenoic acid (DHA) on arachidonic acid metabolism and platelet function. Biochem Biophys Res Commun (1983) 0.92
Ibuprofen protects platelet cyclooxygenase from irreversible inhibition by aspirin. Arteriosclerosis (1983) 0.91
Arachidonate-induced platelet aggregation in the dog. Thromb Res (1979) 0.90
Epinephrine potentiation of arachidonate-induced aggregation of cyclooxygenase-deficient platelets. Am J Hematol (1981) 0.90
An improved method for the extraction of endogenous platelet serotonin. J Lab Clin Med (1976) 0.89
Antisterility and antivitamin K activity of d-alpha-tocopheryl hydroquinone in the vitamin E-deficient female rat. J Nutr (1975) 0.89
Interleukin 1 stimulates endothelial cell tissue factor production and expression by a prostaglandin-independent mechanism. Thromb Haemost (1986) 0.88
Human platelet activation by an alkylacetyl analogue of phosphatidylcholine. Biochim Biophys Acta (1982) 0.88
The influence of glutathione depleting agents on human platelet function. Thromb Res (1989) 0.87
The influence of reserpine and ethylenediaminetetraacetic acid (EDTA) on serotonin storage organelles of blood platelets. Am J Pathol (1977) 0.86
Platelet storage pool deficiency and prostaglandin synthesis in chronic granulocytic leukaemia. Br J Haematol (1978) 0.84
Effects of 2,2'-dipyridyl and related compounds on platelet prostaglandin synthesis and platelet function. Biochim Biophys Acta (1980) 0.83
Modification of human platelet response to sodium arachidonate by membrane modulation. Prostaglandins Med (1981) 0.83
5-Fluorouracil-loaded chitosan coated polylactic acid microspheres as biodegradable drug carriers for cerebral tumours. J Microencapsul (2001) 0.82
Effect of agents that alter cyclic AMP on arachidonate-induced platelet aggregation in the dog. Blood (1980) 0.82
Influence of the calcium-sensitive fluorophore, Quin 2, on platelet function. Blood (1986) 0.82
Evaluation of modified alginate-chitosan-polyethylene glycol microcapsules for cell encapsulation. Artif Organs (1999) 0.82
Glutathione levels in human platelets display a circadian rhythm in vitro. Thromb Res (1985) 0.82
Influence of pH on the prostacyclin (PGI2) mediated inhibition of platelet function. Prostaglandins Med (1980) 0.82
Platelet aggregation independent of ADP release or prostaglandin synthesis in patients with hermansky-Pudlak syndrome. Prostaglandins Med (1981) 0.81
Changes in pericardial calcification due to antiplatelet agents: in vitro studies. Artif Organs (1998) 0.81
Acute effects of amrinone on regional myocardial and systemic blood flow distribution in the dog. Can J Physiol Pharmacol (1982) 0.81
Induction of GPIb/IX-vWF receptor-ligand translocation on surface-activated platelets. Arterioscler Thromb Vasc Biol (1995) 0.81
The influence of epinephrine on prostacyclin (PGI2) induced dissociation of ADP aggregated plateletes. Prostaglandins Med (1980) 0.80
Action of guanosine 5'-[beta-thio]diphosphate on thrombin-induced activation and Ca2+ mobilization in saponin-permeabilized and intact human platelets. Biochem J (1988) 0.80
Thermosensitization by increasing intracellular acidity with amiloride and its analogs. Int J Radiat Oncol Biol Phys (1994) 0.80
Inhibition of prostaglandin (PG) synthesis in sheep vesicular gland microsomes (SVGM) by nitroblue tetrazolium (NBT) and vitamin E (VE). Prostaglandins Med (1979) 0.79
Role of arachidonic acid metabolism in human platelet activation and irreversible aggregation. Am J Hematol (1985) 0.79
Colchicine encapsulation within poly(ethylene glycol)-coated poly(lactic acid)/poly(epsilon-caprolactone) microspheres-controlled release studies. Drug Deliv (2001) 0.79
Effect of Amrinone, a cardiotonic drug, on hemodynamics and platelet function. Prostaglandins Med (1981) 0.79
Retention of glycoprotein Ib/IX receptors on external surfaces of thrombin-activated platelets in suspension. Blood (1995) 0.79
Smoking and platelet labile aggregation stimulating substance (LASS) synthesizing activity. Thromb Res (1976) 0.79
Irreversible platelet aggregation does not depend on lipoxygenase metabolites. Biochem Biophys Res Commun (1985) 0.79
Low dose aspirin, platelet function and prostaglandin synthesis: influence of epinephrine and alpha adrenergic blockade. Prostaglandins Med (1981) 0.79
Phospholipase A2 activation in human neutrophils requires influx of extracellular Ca2+ and leukotriene B4. Am J Physiol (1995) 0.79
Effect of acetaminophen and salicylate on aspirin-induced inhibition of human platelet cyclo-oxygenase. Prostaglandins Leukot Med (1982) 0.79
Redistribution of GPIb/IX and GPIIb/IIIa during spreading of discoid platelets. Br J Haematol (1995) 0.78
Development of poly(Lactic acid)/chitosan co-matrix microspheres: controlled release of taxol-heparin for preventing restenosis. Drug Deliv (2001) 0.78
Effects of nitroblue tetrazolium and vitamin E on platelet ultrastructure, aggregation, and secretion. Am J Pathol (1977) 0.78
Influence of esterase inhibitors on platelet aggregation and release induced by phorbol myristate acetate. Biochem Pharmacol (1975) 0.78
The influence of vitamin E quinone on platelet structure, function, and biochemistry. Blood (1980) 0.78
Functional platelets after storage in vitro for 15--21 days. Am J Pathol (1980) 0.78
The role of iron in prostaglandin synthesis: ferrous iron mediated oxidation of arachidonic acid. Prostaglandins Med (1978) 0.78
Effect of low dose prostacyclin infusion on blood flow in acutely ischemic canine myocardium. Prostaglandins Med (1980) 0.77
Problem with aspirin as antithrombotic agent in coronary artery disease. Lancet (1988) 0.77
Signal transduction, second messengers, and platelet function. J Lab Clin Med (1993) 0.77
Disaggregation and reaggregation of 'irreversibly' aggregated platelets: a method for more complete evaluation of anti-platelet drugs. Agents Actions (1985) 0.77
Inhibition of platelet aggregation by novel triphenylethylene analogs. Thromb Res (1986) 0.77
Enteric-coated aspirin, platelet cyclooxygenase activity and function. Prostaglandins Leukot Med (1984) 0.77
Evaluation of heparin immobilized chitosan-PEG microbeads for charcoal encapsulation and endotoxin removal. Artif Cells Blood Substit Immobil Biotechnol (2000) 0.77
Comparative pharmacology of cyclooxygenase inhibitors on platelet function. Prostaglandins Leukot Med (1985) 0.77
Tranylcypromine induced hypertension is not mediated by the inhibition of prostacyclin synthesis. Prostaglandins Med (1979) 0.77
Aspirin treatment reduces platelet resistance to deformation. Arteriosclerosis (1987) 0.77
Differential sensitivity of regional vascular beds in the dog to low-dose prostacyclin infusion. Can J Physiol Pharmacol (1980) 0.76
Proceedings: Differences in platelet storage pool deficiency (SPD) of Hermansky Pudlak syndrome (HPS) and non-albinos (NA). Thromb Diath Haemorrh (1975) 0.76
Platelet adhesion to novel phospholipid materials: modified phosphatidylcholine covalently immobilized to silica, polypropylene, and PTFE materials. J Biomed Mater Res (1996) 0.76
Platelet function in adolescent idiopathic scoliosis. Spine (Phila Pa 1976) (1992) 0.76
Inhibition of ferrous iron induced oxidation of arachidonic acid by indomethacin. Prostaglandins Med (1979) 0.76
Vessel wall arachidonate metabolism after angioplasty: possible mediators of postangioplasty vasospasm. Am J Cardiol (1983) 0.76
Reduction of heme by lipid peroxides and its potential relevance to understanding control of cyclo-oxygenase activity. Prog Lipid Res (1981) 0.76
Rapid return of cyclo-oxygenase active platelets in dogs after a single oral dose of aspirin. Prostaglandins (1981) 0.76
Influx of extracellular calcium and agonist-coupling appear essential for the activation of thromboxane A2-dependent phospholipase A2 in human platelets. Prostaglandins Leukot Essent Fatty Acids (1995) 0.75
Epinephrine and platelet function. J Lab Clin Med (1997) 0.75
Role of platelet adhesion and aggregation in thrombus formation. Thromb Haemost (1998) 0.75
Prelabeled glycoprotein Ib/IX receptors are not cleared from exposed surfaces of thrombin-activated platelets. Am J Pathol (1996) 0.75
Modifications in accessibility of membrane glycoproteins, binding of specific ligands and coagulation factor V during the activation of platelets in blood emerging from bleeding time wounds. Am J Hematol (1999) 0.75
Arachidonic acid peroxidation, prostaglandin synthesis and platelet function. Photochem Photobiol (1979) 0.75
Human platelet activation is inhibited by the occupancy of glycoprotein IIb/IIIa receptor. Arch Biochem Biophys (1996) 0.75
Aggregated-disaggregated, refractory platelets retain sensitivity to ristocetin. Thromb Res (1996) 0.75
Platelet adhesion and spreading on protein-coated surfaces: variations in behavior in washed cells, PRP, and whole blood. J Biomater Appl (1998) 0.75
Surface-immobilized biomolecules on albumin modified porcine pericardium for preventing thrombosis and calcification. Int J Artif Organs (1999) 0.75
Ultrastructural expression of P-selectin on surface activated platelets. Platelets (1996) 0.75
Rapid separation of tumor-promoting agents, phorbol and phorbol myristate acetate (12-o-tetradecanoylphorbol-13-acetate) by high-pressure liquid chromatography. J Chromatogr (1974) 0.75
The influence of metabolities on the assay of platelet serotonin. Thromb Res (1977) 0.75
Thrombin-induced inhibition of platelet agglutination by von Willebrand factor (vWF): reversal by ionized calcium. Platelets (1996) 0.75
Disappearance of Ising nature in Ca3ZnMnO6 studied by high-field ESR. J Phys Condens Matter (2014) 0.75
Ferrous iron mediated oxidation of arachidonic acid: studies employing nitroblue tetrazolium (NBT). Prostaglandins Med (1978) 0.75
Influence of cytochalasin B (CB) on GP Ib distribution after thrombin or TRAP and before surface activation. Platelets (1997) 0.75
Aflatoxin detection by high-speed liquid chromatography and mass spectrometry. J Chromatogr (1973) 0.75